Ramona
Ramona Optics develops proprietary MCAM (Multi-Camera Array Microscope) imaging systems and AI-powered analysis software, serving pharmaceutical, biotech, academic, and government research customers with high-throughput live-cell and small model organism imaging at up to 24x conventional speeds.
- Company typePrivate
- Founded2018
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ramona does
Ramona Optics, Inc. is a privately held biotechnology instrumentation company headquartered in Durham, North Carolina (incorporated in Delaware) that develops high-throughput microscopy tools built around its proprietary MCAM (Multi-Camera Array Microscope) platform. The MCAM architecture uses 24 or 48 micro-cameras operating in parallel to capture entire well plates simultaneously rather than scanning sequentially, delivering quoted throughput up to 24x faster than conventional microscopes — with the company stating capacity for 1,000 plates per day at 1,000 conditions per plate. All systems are compatible with standard SBS well plates (6–1,536 wells) and include a formal Web API for robotic lab integration.
The company sells three integrated products: Vireo™ (a live-cell imaging system for cells and organoids launched at SLAS2025), Kestrel™ (an imaging system for small model organisms including zebrafish at video rates above 150fps), and MCAM™ Software (an AI-powered multiwell analysis platform using Vision Transformers, automated segmentation, and 10x video compression). Research-stage extensions include PANORAMA, FiLM-Scope, and ReFLeCT platforms published in 2025, plus Momentum™ workflow scheduling software for longitudinal studies. The technology originated from computational microscopy research at Duke University by the founders, and the company has received sustained SBIR/STTR support from NIH, NCI, NSF, and NIBIB.
Ramona generates revenue through one-time capital equipment sales of Vireo and Kestrel systems, recurring software platform access, and professional services including installation, training, and field application scientist support. Pricing is quote-based with multi-year enterprise contracts, delivered via direct enterprise field sales with a prominent "Book a Demo" CTA and active participation at conferences such as SLAS, AACR, SOT, and the International Zebrafish Conference. Customers span pharmaceutical and biotech firms (including Regeneron), academic universities (UNC, Oregon State, NC State, UCSF, University of Chicago), government research institutions, and contract research organizations. A March 2026 SEC Form D filing indicates $26M+ raised of a $31M equity offering from 32 investors to fund working capital as the company scales commercial operations.
Ramona firmographics
Firmographics- Name
- Ramona
- Legal name
- Ramona Optics, Inc.
- Website
- https://ramonaoptics.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ramona Optics develops proprietary MCAM (Multi-Camera Array Microscope) imaging systems and AI-powered analysis software, serving pharmaceutical, biotech, academic, and government research customers with high-throughput live-cell and small model organism imaging at up to 24x conventional speeds.
- Ownership category
- akta.pro rank
Ramona industry classification
Industry- Product category
- Scientific Microscopy Instrumentation
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where Ramona is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Ramona business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Hardware Systems Sales: Sale of Vireo and Kestrel microscope systems. These are high-value capital equipment instruments priced as complete systems with varying configurations. Systems include integrated hardware and proprietary software.
- MCAM Software Platform: AI-powered multiwell image analysis software platform sold as part of system packages or potentially separately. Includes real-time data processing, advanced visualization, and machine learning tools for image capture and data featurization.
- Professional Services & Support: Installation, training, and ongoing technical support services for microscope systems. Field application scientists provide onboarding and optimization support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise microscope systems with custom pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Ramona product offering
Product offeringCore offering
Ramona develops and sells high-throughput microscopy instruments powered by its proprietary MCAM (Multi-Camera Array Microscope) technology, which uses 24 parallel micro-cameras to image entire well plates simultaneously rather than sequentially. Its commercial product line includes the Vireo™ live-cell imaging system, the Kestrel™ small model organism imaging system, and the MCAM™ Software platform for AI-powered multiwell image analysis, sold primarily to pharmaceutical companies, biotech firms, government research entities, and academic universities.
Product overview
Ramona offers a unified product portfolio centered on high-throughput live-cell imaging. The core offering consists of three integrated products: Vireo™ (world's fastest live-cell imaging system for cells and organoids), Kestrel™ (imaging system for small model organisms including zebrafish), and MCAM™ Software (AI-powered multiwell image analysis platform). All products are powered by Ramona's proprietary MCAM™ (Multi-Camera Array Microscope) technology featuring 24-camera parallel imaging. The portfolio solutions for teams tackling quality control, high-throughput drug screening, and real-time cellular dynamics with precision and speed.
Differentiator
Problem solved
Functional benefit
Brands
- Vireo™: World's fastest live-cell imaging system - a 4D imaging system with MCAM Technology for studying cells and organoids.
- Kestrel™
- MCAM™ Software
- MCAM™ (Multi-Camera Array Microscope)
Products and services
- Vireo™ The world's fastest live-cell imaging system that uses MCAM Technology for 4D imaging of cells and organoids, delivering 1-minute per plate processing, 24x parallelized video capture, and multi-channel fluorescence for non-destructive assessment of cellular function and dynamics.
- Kestrel™ The ultimate imaging system for small model organisms that performs high-throughput behavioral, morphological, and fluorescence analysis of entire plates of zebrafish and other model organisms at video rates above 150fps.
- MCAM™ Software AI-powered multiwell image analysis platform that streamlines high-throughput imaging with an automation API, real-time machine learning analysis, Vision Transformer-based video encoding, and tools to translate image data into quantifiable metrics.
- Momentum™ Workflow Scheduling Software Workflow scheduling software for the MCAM platform that enables revisiting well plates over prolonged periods to support longitudinal studies.
Quantifiable outcome
- 24x throughput increase across wells - entire 96-well plate imaged in 30 seconds (4X) or 2 minutes (10X)
- +5 more outcomes
Companies that use Ramona
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
Ramona technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature7 records
Ramona partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Gregor Horstmeyer (CEO Signatory)coreGregor Horstmeyer serves as CEO and signed the March 2026 SEC Form D filing as the authorized signatory of Ramona Optics, Inc.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
Ramona competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Sells a broad portfolio of life-science microscopy and cell-imaging instruments (e.g., Evos, CellInsight, DMI8) and offers wider workflow solutions; not specialized to Ramona's parallel-camera architecture but a major incumbent in lab imaging.
- Bruker: Provides advanced microscopy and cellular-analysis instruments (e.g., Vutara, Luxendo light-sheet). Adjacent to Ramona's high-content screening focus with broader structural and super-resolution capabilities.
- Carl Zeiss Microscopy: Sells high-end research microscopes (Celldiscoverer 7, Axio Observer, LSM) used in cell biology and screening; broader portfolio than Ramona and focused on premium research-grade imaging rather than plate-scale throughput.
- Nikon Instruments: Markets Eclipse Ti2-E and BioStation CT for live-cell imaging and high-content screening; overlaps with Ramona's pharma/biotech customer base but with broader, general-purpose microscope offerings.
- Leica Microsystems: Danaher-owned microscopy provider offering THUNDER, STELLARIS, and DMI8 systems. Competes in advanced live-cell imaging but lacks Ramona's parallel-camera high-throughput plate-imaging specialization.
Direct peers
- Revvity: Spun off from PerkinElmer, Revvity sells the Opera Phenix and Operetta high-content screening systems that compete head-to-head with Ramona's Vireo for cell and organoid imaging in pharma drug discovery.
- Molecular Devices: Subsidiary of Danaher (via Fortive spin) that manufactures high-content screening microscopes including the ImageXpress platform — directly comparable high-throughput live-cell imaging systems sold to pharma and academic drug-screening labs.
- Agilent Technologies (BioTek): Acquired BioTek and sells the Cytation series of imaging multimode readers and high-content screening systems, directly competing with Ramona's high-throughput plate-imaging workflow for pharma and academic screening.
- Yokogawa Electric: Sells the CellVoyager CV8000 and CQ1 high-content screening microscopes — established parallel-imaging alternatives targeting the same drug-screening and 3D cell biology applications as Ramona's MCAM technology.
Emerging players
- Hamamatsu Photonics: Provides imaging components (sCMOS cameras, NanoZoomer slide scanners) and is increasingly active in high-throughput cellular imaging. Component supplier overlap with Ramona's camera-array architecture and an emerging player in integrated HCS systems.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Ramona social profiles
Digital presenceRamona financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ramona leadership team
Management profileNumber of profiles
Profiles10 records
Ramona funding detail
Funding detailFunding overview
Funding rounds17 records
Investors15 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ramona M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ramona
What does Ramona do?
Ramona develops and sells high-throughput microscopy instruments powered by its proprietary MCAM (Multi-Camera Array Microscope) technology, which uses 24 parallel micro-cameras to image entire well plates simultaneously rather than sequentially. Its commercial product line includes the Vireo™ live-cell imaging system, the Kestrel™ small model organism imaging system, and the MCAM™ Software platform for AI-powered multiwell image analysis, sold primarily to pharmaceutical companies, biotech firms, government research entities, and academic universities.
Is Ramona a public or private company?
Ramona is a private company. It is classified as venture growth investor backed and is currently operating.
When was Ramona founded?
Ramona was founded in 2018. It employs 11 to 50 people.
Where is Ramona based?
Ramona is headquartered in Durham, United States, in the North America region.
How does Ramona make money?
Three revenue lines are on record. Hardware Systems Sales are the primary driver. The others are MCAM Software Platform and professional Services & Support.
Who are Ramona's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, Bruker, Carl Zeiss Microscopy, Nikon Instruments and Leica Microsystems. Direct peers are Revvity, Molecular Devices, Agilent Technologies (BioTek) and Yokogawa Electric. Hamamatsu Photonics is listed as an emerging player.
Does Ramona have an API?
Yes. Ramona offers a Formal Web API for automation integration. The Vireo product page states 'Automation Integration: Formal Web API' and 'Robot-ready - Compatible with scheduling software through a formal Web API.' The MCAM Software page mentions 'Automated imaging with WebMCAM API.' The API enables developers to build automated workflows and integrate Ramona systems into robotic and scheduling workflows for maximum throughput.
What industry is Ramona in?
Ramona's product category is Scientific Microscopy Instrumentation. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 334516 and its SIC code is 3826.